Engraftment Syndrome After Autologous Stem Cell Transplant: Retrospective Review in Patients With Multiple Myeloma

N/ACompletedNCT01622582

University of Arkansas796 enrolled

Overview

Engraftment Syndrome after Autologous Stem Cell Transplant: Retrospective Review in Patients with Multiple Myeloma

A retrospective chart review series will be performed fpr subjects enrolled from 1/1/2006.

Study Type

OBSERVATIONAL

Enrollment

796

Conditions

Multiple Myeloma

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with Multiple Myeloma, developing engraftment syndrome Exclusion Criteria: * Patients with Multiple Myeloma, with no features of engraftment syndrome

Locations (1)

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States

Outcomes

Primary Outcomes

number of patients developing Engraftment syndrome following stem cell transplant

A retrospective review where subjects medical records are studied for development of engraftment syndrome 6 months after stem cell transplant

Time frame: 6 months post-transplant

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.